Evidence depth: moderate · High public-data fit

Urology

A premier surgical subspecialty balancing high-volume, quick outpatient procedures with a robust ASC/ownership ecosystem. Often considered one of the best lifestyle-to-income ratios in surgery.

Build Your Report RVU calculator All specialties

Where to start

Best-fit Urology paths

Directional, modeled. Your priorities decide. Build a report to make it yours.

If you want the highest income

General Urology

High, volume-driven.

$490k - $625k

See this path →

If you want the best lifestyle

Urologic Oncology / Robotics

Moderate-High.

$530k - $675k

See this path →

If you want ownership upside

General Urology

High, volume-driven.

$490k - $625k

See this path →

Data Highlights

Specialty Insights

Public data · NPPES14,628 clinicians in the NPI registry roster. Registration, not verified active practiceTop states: CA, NY, FLAggregate workforce/geography, not income.

Competitiveness context: very competitive - NRMP 2024

394 positions offeredvery high applicants-per-position tierAUA Urology Match 2024 published summary

Modeled Paths: 2
Top Modeled Ceiling: $800k - $1.2M+
Best Lifestyle Path: General Urology
Highest Equity Upside: General Urology

Public data · CMS Medicare Part B

What this specialty actually bills Medicare

Reviewed. Medicare procedure mix mapped

Aggregate allowed amount: $1.5B; Medicare Part B, not income
Providers in panel: 14,935; NPPES individual NPIs
NPI → Medicare join: 59%; billed Medicare in the year
Open Payments physicians: 9,554; transfers of value, not income

Medicare allowed-$ by subspecialty sector (public CMS data)

General Urology

$308M

Top procedures by Medicare allowed-$ (public CMS data)

52000 · Diagnostic exam of bladder and urethra using an endoscope$133M
52356 · Crushing of stone of ureter with insertion of stent using an endoscope$23M
55700 · Biopsy of prostate gland$19M
51728 · Complex measurement of pressure of urine flow in bladder with voiding pressure studies$18M
76872 · Ultrasound scan of pelvic region through rectum$15M

Source: CMS Medicare Physician & Other Practitioners (public). This is not W-2 salary, total collections, or take-home income. Aggregate allowed amounts are a partial, biased slice of one payer; sector labels are keyword-inferred from public procedure descriptions and are directional, pending physician review.

Paths

Path families to test

General Urology

High, volume-driven.

External benchmark reference: ~$500k

DoctorCalculator modeled estimate: Owner/Partner Ceiling: $800k - $1.2M+

View path →

Urologic Oncology / Robotics

Moderate-High.

External benchmark reference: ~$480k

DoctorCalculator modeled estimate: Ceiling: $550k - $750k

View path →

Path Landscape

Compare all 2 paths

Premium tool

Unlock 10-dimension comparison matrix

See exactly how every path stacks up across lifestyle, sleep, ownership, and income.

Unlock premium

Path battle card

Compare head-to-head

Path A

Path B

Urology

General Urology

Really about: high-volume outpatient procedures with strong ASC and ancillary upside

validated confidence

Urology

Urologic Oncology / Robotics

Really about: complex robotic surgery, cancer care, and academic prestige

validated confidence

1. Income ceilingedge → General Urology: Favorable
A very strong ceiling driven by ancillary services and massive procedure volume.
The reality · The signal · The catch · The verdict
The reality: In-clinic procedures (cystoscopies, TRUS biopsies, vasectomies) are highly efficient and scale beautifully.
The signal: ASC ownership, lithotripsy joint ventures, and in-house pathology labs act as massive multipliers on your base income.
The catch: Mega-groups have optimized billing, contracting, and leverage, pushing the ceiling higher for partners.
The verdict: Provides an excellent, top-tier ceiling for a specialty with a highly controllable lifestyle.; Mixed
Solid, but often lower than general urology due to case length.
The reality · The signal · The catch · The verdict
The reality: Massive oncologic resections (like robotic cystectomies) take hours and generate poor RVUs per minute.
The signal: Academic salaries are structurally lower than private mega-group compensation.
The catch: If employed by a hospital, you lose the massive ASC and pathology ownership upside.
The verdict: This is a prestige and complexity-driven path, not a pure wealth-maximizer.
2. Lifestyle controledge → General Urology: Favorable
Excellent control; one of the most predictable schedules in surgery.
The reality · The signal · The catch · The verdict
The reality: The practice is overwhelmingly outpatient, elective, and scheduled well in advance.
The signal: You have immense power to control the pace of your clinic and your surgical block time.
The catch: Even major robotic cases (prostatectomies, nephrectomies) are scheduled and rarely emergent.
The verdict: An elite choice for those who want surgical skills but demand a predictable family life.; Mixed
Lower control than general urology due to case complexity.
The reality · The signal · The catch · The verdict
The reality: Major robotic cancer cases can run late into the evening if complications arise.
The signal: You are tethered to the hospital OR schedule and often fight for robotic block time.
The catch: The patients are sicker and require more complex post-operative management.
The verdict: Significantly less predictable than a pure outpatient clinic practice.
3. Sleep / call burdenedge → General Urology: Favorable
Very low burden; highly protective of your sleep.
The reality · The signal · The catch · The verdict
The reality: True urologic emergencies (testicular torsion, gross hematuria with clot retention) exist but are infrequent overnight.
The signal: Call is predominantly taking phone consults for catheter issues from the ER or nursing floors.
The catch: In many trauma centers, general surgery handles the acute multi-system trauma.
The verdict: An ideal surgical path for those who require protected sleep to function well.; Mixed
Low to moderate, mostly managing your own post-operative complications.
The reality · The signal · The catch · The verdict
The reality: Major pelvic surgeries can have complex complications (bleeds, leaks) that wake you up.
The signal: However, there are very few true, middle-of-the-night urologic oncology emergencies.
The catch: Your call burden is primarily dictated by whether you are forced to take general urology stone call.
The verdict: Highly manageable compared to trauma or vascular surgery.
4. Ownership / facility upsideedge → General Urology: Favorable
Massive upside driven by the 'golden triad' of urologic ancillaries.
The reality · The signal · The catch · The verdict
The reality: True wealth is built by owning the ASC, the Lithotripsy machine (often a mobile JV), and the Pathology lab.
The signal: You capture the professional surgical fee, the facility fee, and the highly lucrative ancillary reads.
The catch: This massive, diversified revenue stream is exactly why Private Equity is aggressively buying urology practices.
The verdict: A classic, highly proven owner-operator playbook that decouples your income from your time.; Costly
Significantly lower than general urology, heavily dependent on employment model.
The reality · The signal · The catch · The verdict
The reality: Massive cancer resections cannot be done in an ASC; they require full hospital infrastructure.
The signal: If you are academically employed, you have zero equity.
The catch: If you practice oncology within a private mega-group, you may still share in the pathology/ASC profits.
The verdict: Generally a poor fit for pure owner-operator wealth building.
5. Geography flexibilityedge → General Urology: Favorable
Universal demand ensures you can practice almost anywhere.
The reality · The signal · The catch · The verdict
The reality: Everyone has kidneys, and an aging male population guarantees a permanent demand for prostate care.
The signal: It is exceptionally easy to find a job in desirable metropolitan areas and community hospitals.
The catch: However, mega-groups heavily dominate some markets, completely stifling independent solo options.
The verdict: Offers excellent geographic freedom, though you may have to join the local monopoly.; Mixed
Tethered to tertiary centers and major robotic programs.
The reality · The signal · The catch · The verdict
The reality: You cannot practice complex urologic oncology in a small rural hospital without a Da Vinci robot and an ICU.
The signal: Your job search is restricted primarily to larger metropolitan areas and academic hubs.
The catch: There are fewer jobs available compared to the ubiquitous demand for general urology.
The verdict: Offers moderate geographic freedom, but reduces your negotiating leverage.
6. Innovation / industry adjacencyedge → Urologic Oncology / Robotics: Mixed
Moderate, heavily focused on surgical robotics and office-based tech.
The reality · The signal · The catch · The verdict
The reality: You will heavily utilize the Da Vinci robot for pelvic and renal cases.
The signal: There is constant device innovation in minimally invasive BPH treatments (UroLift, Rezum, Aquablation).
The catch: While there are some consulting opportunities, it is not a massive driver of wealth compared to facility ownership.
The verdict: The primary focus remains on business scaling and volume rather than massive tech disruption.; Favorable
High, heavily focused on surgical robotics and oncology clinical trials.
The reality · The signal · The catch · The verdict
The reality: You will be at the absolute forefront of advanced robotic techniques and pelvic reconstruction.
The signal: There is significant overlap with medical oncology and targeted therapies for prostate/kidney cancer.
The catch: Offers some consulting opportunities with robotic manufacturers (Intuitive).
The verdict: An intellectually stimulating path that bridges advanced surgery with cutting-edge cancer care.
7. Training opportunity costedge → General Urology: Mixed
Requires a highly competitive 5-year residency.
The reality · The signal · The catch · The verdict
The reality: A standard, predictable surgical training pathway.
The signal: The Urology match is notoriously competitive to enter, requiring top-tier board scores and research.
The catch: Crucially, no fellowship is required to reach the absolute top income tiers.
The verdict: Features an excellent, highly rational financial ROI on your training years.; Mixed
Requires a 5-year residency plus a highly competitive 1-2 year fellowship.
The reality · The signal · The catch · The verdict
The reality: The Urologic Oncology fellowship (SUO) is rigorous and highly sought after for academic positions.
The signal: Carries the massive opportunity cost of delaying your attending salary by up to two years.
The catch: The fellowship rarely increases your absolute pay; you do it for the case mix and prestige.
The verdict: A demanding path reserved for true academic purists.
8. Job-market densityedge → General Urology: Favorable
Very strong demand driven by inescapable demographics.
The reality · The signal · The catch · The verdict
The reality: A massive aging population drives endless demand for both oncology and benign prostatic hyperplasia (BPH) care.
The signal: Both hospital-employed and private mega-group roles are incredibly plentiful nationwide.
The catch: The real challenge is finding an independent group with a fair, transparent partnership track before PE buys them.
The verdict: You will have ultimate job security in this field.; Mixed
A narrower, highly competitive market for the top academic spots.
The reality · The signal · The catch · The verdict
The reality: Jobs are scarce because a hospital only needs one or two dedicated urologic oncologists.
The signal: The premier academic positions have very low turnover.
The catch: You will likely have to do some general urology to justify your salary in a community setting.
The verdict: Requires aggressive networking and a willingness to compromise on location.
9. Malpractice / litigation pressureedge → General Urology: Mixed
Relatively low compared to high-acuity surgical specialties.
The reality · The signal · The catch · The verdict
The reality: Complications (incontinence, erectile dysfunction) are known, consented risks and usually manageable.
The signal: The overall acuity of the patients is much lower than in neurosurgery or cardiac surgery.
The catch: Maintains a highly manageable medico-legal profile.
The verdict: Much lower baseline stress than specialties that deal constantly with death and severe morbidity.; Mixed
Moderate; cancer surgery has high stakes but a strong medico-legal buffer.
The reality · The signal · The catch · The verdict
The reality: The patients understand the dire nature of their cancer, mitigating some lawsuit risk.
The signal: However, catastrophic complications (bowel injury, massive hemorrhage) during pelvic surgery are highly scrutinized.
The catch: Requires meticulous robotic technique and thorough pre-operative counseling.
The verdict: A manageable risk profile for a high-acuity field.
10. Burnout-mismatch riskedge → General Urology: Favorable
Low risk, provided you do not mind repetitive clinic volume.
The reality · The signal · The catch · The verdict
The reality: If you hate high-volume clinic and the monotony of doing 20 vasectomies in a row, you will quickly burn out.
The signal: Requires a 'factory' mindset to efficiently process the high volume of minor complaints.
The catch: An absolutely excellent fit for wealth-builders and lifestyle-seekers who want surgical skills.
The verdict: Low mismatch risk if you understand the clinical reality of the specialty.; Mixed
Moderate risk if you expected the relaxed lifestyle of general urology.
The reality · The signal · The catch · The verdict
The reality: Requires a strong academic or complex reconstructive identity to survive the longer hours and lower relative pay.
The signal: If you chose this for prestige but actually want to go home at 5 PM, you will suffer.
The catch: You must truly love the anatomy and the cancer patient population.
The verdict: A fantastic fit for the academic surgeon, but a poor choice for the lifestyle-seeker.
11. What people regret: • Assuming all partners make the same, only to realize the senior partners own the ASC real estate and you are just generating RVUs.
• The mind-numbing repetition of performing 20 vasectomies and cystoscopies a day.; • Realizing that doing a 6-hour robotic cystectomy pays less than your partner doing 6 quick laser lithotripsies.
• Sacrificing your income for academic prestige.
12. Best-fit archetypes: Owner-Operator Physician, Lifestyle-First Clinician; Prestige-Risk Academic, Procedure-Heavy Wealth Builder
13. Poor-fit archetypes: Prestige-Risk Academic; Lifestyle-First Clinician
14. Questions to ask mentors / fellowships / jobs: • What is the exact buy-in structure and timeline for the ASC, the lithotripsy joint venture, and the pathology lab?
• How is the massive volume of clinic procedures (cystoscopies, vasectomies) distributed among junior vs senior partners?
• Are there private equity restrictions or onerous non-competes in this specific market?; • Do you have dedicated block time for the robot, or are you fighting general surgery for access?
• Are you required to take general urology call (kidney stones, catheters) in addition to your oncology cases?

Evidence & reveals

Clinician assumptionmoderate

Urology wealth relies heavily on ancillary ownership (ASC, Litho).

Why · signal · limit · impact

Why: Without ancillaries, the ceiling is capped by simple RVU production.

Signal: Industry data shows mega-groups capture massive ancillary revenue.

Caveat: Do not take a private job without a clear path to ASC/ancillary ownership.

Impact: Push for ownership.

Curated field notemoderate

Urologic oncology pays less per hour than general urology.

Why · signal · limit · impact

Why: The RVU system severely punishes long, complex cases.

Signal: Hospital employment strips the ownership upside.

Caveat: Choose this path for the prestige and the medicine, not the money.

Impact:

Scores are relative, directional signals, not dollars and never a salary claim. Each carries its own why, supporting signal, limitation, and decision impact, and the confidence badge shows how validated each path is.

Field notes

Urology is highly consolidated in many markets (mega-groups), which provides strong ancillary income but makes starting a solo practice very difficult.

Common regret patterns

Joining a mega-group and realizing the path to partnership is 5 years long and heavily diluted by private equity.
Getting stuck doing endless cystoscopies when you wanted to do major robotics.

Questions to ask

Where did recent graduates land, and at what real compensation model?
What's the realistic path to ownership or production upside?

Run your personalized report

Premium turns your target life into a required-income number, then tests it against these paths for salary-only gap, ownership upside, call burden, and geography. Evidence depth and confidence stay visible inside every report.

Build Your Report